FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
FDA General

Gottlieb, McClellan Hit FDA Reorganization Plan

Former FDA commissioners Scott Gottlieb and Mark McClellan voice concerns about an HHS proposed reorganization of FDA that would centralize the review...

latest-news-card-1

Michael Rogers Resigns from FDA

CBS News reports that FDA associate commissioner for inspections and investigations Michael Rogers is retiring, frustrated over changes being made by ...

latest-news-card-1
FDA General

FDA Picks Booz Allens Walsh as AI Chief

FDA taps former Booz Allen Hamilton chief technologist Jeremy Walsh to lead its artificial intelligence (AI) and information technology efforts in a n...

FDA General

Teva/Alvotechs Interchangeable Stelara Biosimilar OKd

FDA approves Teva Pharmaceuticals and Alvotechs Selarsdi injection as an interchangeable biosimilar to Janssens reference biologic Stelara (ustekinuma...

latest-news-card-1
FDA General

Inspection Disruptions Wont Rise to Covid Level: Expert

Former CDER Office of Compliance director Don Ashley says inspection disruptions caused by recent FDA reductions in force will not rise to the level o...

Animal Drugs

Therivas Pancreatic Cancer Drug Hits Endpoints

Theriva Biologics reports positive Phase 2b VIRAGE topline results for its VCN-01 when added to standard of care chemotherapy to treat a form of pancr...

Biologics

Moderna Flu/Covid Vaccine Beats Comparators: Study

A Moderna Phase 3 study says its combination mRNA flu and Covid-19 vaccine achieved a greater immune response than comparator standard of care vaccine...

Human Drugs

Omeros BLA Resubmission for Narsoplimab

FDA accepts for review an Omeros BLA resubmission for narsoplimab for treating hematopoietic stem cell transplant-associated thrombotic microangiopath...

latest-news-card-1
FDA General

Bill Would Create FDA Inspector General

Sen. Eric Schmitt introduces legislation to create an inspector general for FDA and two other public health agencies.

latest-news-card-1
Human Drugs

Oncologic Panel to Review 4 Cancer Submissions

FDA announces a 5/20-21 Oncologic Drugs Advisory Committee meeting to review and vote on four cancer drug submissions.